Navigation Links
Lilly Receives Award From National Medical Association
Date:7/27/2009

INDIANAPOLIS, July 27 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) was given the Corporate Circle Partners award by the National Medical Association (NMA) at their 113th annual conference and scientific assembly over the weekend in Las Vegas.

Lilly has developed a long-standing, productive partnership with the NMA to advance specific issues facing patients and to address healthcare disparities.

"We can't do this alone," said Mohammad N. Akhter, M.D., MPH, executive director, National Medical Association. "As strong as the NMA and Lilly are separately, together we have greater impact in this country for the betterment of all of us."

Signature NMA programs such as the Global Health Initiative and policy shaping consensus panel are examples of the collaboration with Lilly. In addition, the NMA continues to actively participate in a Lilly diabetes initiative that serves to empower African Americans to overcome key barriers to success in living with diabetes, the Fearless African-Americans Connected and Empowered (F.A.C.E.) campaign.

Further, in an effort to increase the diversity of its clinical trials, Lilly also utilizes physicians involved in the NMA's Project Impact as clinical trial investigators. Project Impact encourages greater participation of African Americans in all aspects of biomedical research and clinical trials, including supporting African-American physicians in the process.

"We are honored and humbled by this noteworthy acknowledgment," said Jack Harris, M.D., vice president of the U.S. medical division at Lilly. "Lilly shares a common interest with the NMA - to come together to share knowledge that goes beyond medicine to improve individual patient outcomes."

National Medical Association

Founded in 1895, the National Medical Association is the nation's oldest and largest medical association representing the interests of more than 30,000 African-American physicians and their patients. The NMA has repeatedly advocated for policies that would assure equitable and quality health care for all people.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO)

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
2. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
3. Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
4. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
5. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
6. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
7. Lilly Declares Third-Quarter Dividend
8. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
9. Eli Lilly and Company Announces New Drug Discovery Initiative
10. NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
11. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology: